Fibroblast growth factor-2 promotes in vitro mitral valve interstitial cell repair through transforming growth factor-β/smad signaling

American Journal of Pathology

Volumn 178, Issue 1, 2011, Pages 119-127

  Han, Li ^a   Gotlieb, Avrum I ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; SMAD2 PROTEIN; SMAD3 PROTEIN; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 3;

ARTICLE; CELL REGENERATION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; LEYDIG CELL; MITRAL VALVE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; VALVE INTERSTITIAL CELL; WESTERN BLOTTING; WOUND CLOSURE; WOUND HEALING;

EID: 79251480413     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2010.11.038     Document Type: Article

References (27)

1. Liu AC, Joag VR, Gotlieb AI: The emerging role of valve interstitial cell phenotypes in regulating heart valve pathobiology. Am J Pathol 2007, 171:1407-1418
2. Durbin AD, Gotlieb AI: Advances towards understanding valve response to injury. Cardiovasc Pathol 2002, 11:69-77
3. Durbin A, Nadir N, Rosenthal A, Gotlieb AI: Nitric oxide promotes in vitro interstitial cell heart valve repair. Cardiovasc Pathol 2005, 14:12-18 (Pubitemid 40248427)
4. ten Dijke P, Hill CS: New insights into TGF-β-Smad signalling. Trends Biochem Sci 2004, 29:265-273
5. Blobe GC, Schiemann WP, Lodish HF: Role of transforming growth factor β in human diseases. N Engl J Med 2000, 342:1350-1358 (Pubitemid 30408720)
6. Nakao A, Imamura T, Souchelnytskyi S, Kawabata M, Ishisaki A, Oeda E, Tamaki K, Hanai J, Heldin CH, Miyazono K, ten Dijke P: TGF-β receptor-mediated signalling through Smad2, Smad3 and Smad4. EMBO J 1997, 16:5353-5362
7. Shi Y, Massagué J: Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 2003, 113:685-700 (Pubitemid 36724933)
8. Andres JL, DeFalcis D, Noda M, Massagué J: Binding of two growth factor families to separate domains of the proteoglycan betaglycan. J Biol Chem 1992, 267:5927-5930
9. Kaname S, Ruoslahti E: Betaglycan has multiple binding sites for transforming growth factor-β1. Biochem J 1996, 315:815-820
10. Mendoza V, Vilchis-Landeros MM, Mendoza-Hernández G, Huang T, Villarreal MM, Hinck AP, López-Casillas F, Montiel JL: Betaglycan has two independent domains required for high affinity TGF-β binding: proteolytic cleavage separates the domains and inactivates the neutralizing activity of the soluble receptor. Biochemistry 2009, 48: 11755-11765
11. Eickelberg O, Centrella M, Reiss M, Kashgarian M, Wells RG: Betaglycan inhibits TGF-β signaling by preventing type I-type II receptor complex formation. J Biol Chem 2002, 277:823-829
12. Lee JD, Hempel N, Lee NY, Blobe GC: The type II TGF-β receptor suppresses breast cancer progression through GIPC-mediated inhibition of TGF-β signaling. Carcinogen 2010, 31:175-183
13. Liu AC, Gotlieb AI: Transforming growth factor-β regulates in vitro heart valve repair by activated valve interstitial cells. Am J Pathol 2008, 173:1275-1285
14. Cushing MC, Liao J, Anseth KS: Activation of valvular interstitial cells is mediated by transforming growth factor-β1 interactions with matrix molecules. Matrix Biol 2005, 24:428-437 (Pubitemid 41781640)
15. Darby I, Skalli O, Gabbiani G: Alpha-smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. Lab Invest 1990, 63:21-29
16. Bikfalvi A, Klein S, Pintucci G, Rifkin DB: Biological roles of fibroblast growth factor-2. Endocr Rev 1997, 18:26-45
17. Javerzat S, Auguste P, Bikfalvi A: The role of fibroblast growth factors in vascular development. Trends Mol Med 2002, 8:483-489
18. Lemiere S, Azar R, Belloc F, Gürsel D, Pyronnet S, Bikfalvi A, Auguste P: Overexpression of high molecular weight FGF-2 forms inhibits glioma growth factor by acting on cell-cycle progression and protein translation. Exp Cell Res 2008, 314:3701-3711
19. Virag JA, Rolle ML, Reece J, Hardouin S, Feigl EO, Murry CE: Fibroblast growth factor-2 regulates myocardial infarct repair. Am J Pathol 2007, 171:1431-1440
20. Eswarakumar VP, Lax I, Schlessinger J: Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev 2005, 16:139-149 (Pubitemid 40616112)
21. Ortega S, Ittmann M, Tsang S, Ehrlich M, Basilico C: Neuronal defects and delayed wound healing in mice lacking fibroblast growth factor 2. Proc Natl Acad Sci 1998, 95:5672-5677
22. Ribatti D, Nico B, Vacca A, Roncali L, Presta M: Endogenous and exogenous fibroblast growth factor-2 modulate wound healing in the chick embryo chorioallantoic membrane. Angiogenesis 1999, 3:89-95
23. Zhang Z, Coomans C, David G: Membrane heparan sulfate proteoglycan-supported FGF-2-FGFR1 signaling. J Biol Chem 2001, 276: 41921-41929
24. Matsumoto T, Turesson I, Book M, Gerwins P, Claesson-Welsh L: p38 MAP kinase negatively regulates endothelial cell survival, proliferation, and differentiation in FGF-2-stimulated angiogenesis. J Cell Biol 2002, 156:149-160
25. Gotlieb AI, Rosenthal A, Kazemian P: Fibroblast growth factor 2 regulation of mitral valve interstitial cell repair in vitro. J Thorac Cardiovasc Surg 2002, 124:591-597
26. Lester W, Rosenthal A, Granton B, Gotlieb AI: Porcine mitral valve interstitial cells in culture. Lab Invest 1988, 59:710-719
27. Cushing MC, Mariner PD, Liao JT, Sims EA, Anseth KS: Fibroblast growth factor represses Smad-mediated myofibroblast activation in aortic valvular interstitial cells. FASEB J 2008, 22:1769-1777